In this webinar for the Broken Science Initiative Medical Society, Graciano Rubio, owner of MetFix Valley View, provides powerful insights on navigating systems and staying grounded in purpose.
Rubio, known as the Wall Street Weightlifter, delivers a comprehensive presentation outlining the transformative wellness framework he implements at MetFix Valley View. Unlike traditional gym models focused on aesthetics or elite athletic performance, Rubio’s program is rooted in reversing chronic disease and improving everyday functionality. His system is structured around a 90-day on-ramp that includes education, personalized assessments, and consistent tracking through a seven-level progression model. Clients are introduced to foundational fitness principles and taught to measure their progress against their past performance—not others—with the goal of transitioning from sickness to wellness and eventually fitness.
Rubio emphasized that most members aren’t aspiring to become elite athletes; instead, they want to feel better, have more energy, and avoid chronic medications or disease. The program helps clients identify tangible goals, like improving mile time or increasing strength, which correlate with improvements in blood pressure, A1C, and overall quality of life. By providing concrete metrics and frequent assessments, members see meaningful progress on a daily or weekly basis—far more motivating than waiting months between doctor visits. This regular feedback loop reinforces good habits and discourages poor ones, making fitness a sustainable part of life rather than a short-term fix.
Importantly, Rubio’s model is also age-inclusive, with modifications for older adults and realistic benchmarks adjusted by age. His emphasis on community, coaching quality, and individualized roadmaps ensures that members stay engaged for years—not just weeks. For Rubio, health and fitness are ultimately about increasing capacity for life: being able to show up for family, travel without fatigue, and feel confident in your physical abilities. His program is a practical, scalable solution to one of today’s most pressing issues—preventable chronic disease—and is already inspiring both gym owners and individuals to rethink their approach to long-term health.
This BSI Medical Society Webinar was streamed on April 16th, 2025.
A 10-minute summary of the webinar is available here free, for anyone, while the full webinar is available for Medical Society Members in their dashboard.
Let's start with the truth!
Support the Broken Science Initiative.
Subscribe today →
recent posts
Metabolic health, medical education, and the case for bringing clinicians and coaches together
At the 2026 Unbreakable Health Retreat in Miami, Emily Kaplan hosted a panel with Bob Kaplan, Professor Thomas Seyfried, and Dr. Derek Lee on what it means to treat cancer as a metabolic disease. They discussed the glucose-ketone index (GKI), nutritional ketosis, and strategies aimed at restricting the fuels cancer cells depend on while considering how metabolic therapy can fit alongside standard cancer treatment.
The conversation also addressed the practical realities patients face when trying to pursue a metabolic approach within the conventional oncology system, including questions about nutrition, repurposed drugs, inherited cancer risk, and how to evaluate different treatment options. Seyfried and Lee connected these clinical questions back to mitochondrial dysfunction, fermentation, and the metabolic vulnerabilities that may offer additional targets for cancer treatment.
An abbreviated version of this discussion is available here, for free.
At the 2026 Unbreakable Health Retreat in Miami, Professor Thomas Seyfried presented the case that cancer is fundamentally a mitochondrial metabolic disease rather than primarily a genetic one. He contrasts the dominant somatic mutation theory with a metabolic model in which impaired mitochondrial respiration drives a shift toward fermentation, dysregulated cell growth, and the mutations commonly associated with cancer.
Citing the work of Otto Warburg and research from his lab at Boston College, Seyfried explains how cancer cells rely heavily on fermentable fuels—particularly glucose and glutamine—and why mitochondrial dysfunction sits upstream of many of the genetic abnormalities seen in tumors. He also discusses reactive oxygen species, altered cellular signaling, and the role of mitochondria in regulating cell growth and behavior.
The presentation then turns to the therapeutic implications of this model. Seyfried explains strategies aimed at placing tumor cells under metabolic stress by restricting the fuels they depend on, including ketogenic metabolic therapy and approaches targeting glucose and glutamine. For Seyfried, the therapeutic target follows directly from the biology: restrict the fuels cancer cells depend on, exploit their metabolic weaknesses, and treat mitochondrial dysfunction as the central feature of the disease.
An abbreviated version of this discussion is available here, for free.
MetFix and BSI Members can view the full 54-minute video.
